BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22521297)

  • 1. Resistant hypertension and aldosterone: an update.
    Clark D; Ahmed MI; Calhoun DA
    Can J Cardiol; 2012 May; 28(3):318-25. PubMed ID: 22521297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
    Gaddam KK; Pratt-Ubunama MN; Calhoun DA
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):353-9. PubMed ID: 16716096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advancements in the treatment of resistant hypertension.
    Clark D; Guichard JL; Calhoun DA; Ahmed MI
    Postgrad Med; 2012 Jan; 124(1):67-73. PubMed ID: 22314116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and pharmacologic approach to patients with resistant hypertension.
    Adams M; Bellone JM; Wright BM; Rutecki GW
    Postgrad Med; 2012 Jan; 124(1):74-82. PubMed ID: 22314117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Resistant and Refractory Hypertension.
    Acelajado MC; Hughes ZH; Oparil S; Calhoun DA
    Circ Res; 2019 Mar; 124(7):1061-1070. PubMed ID: 30920924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of patients with resistant hypertension: the RESIST-POL study.
    Florczak E; Prejbisz A; Szwench-Pietrasz E; Sliwiński P; Bieleń P; Klisiewicz A; Michałowska I; Warchoł E; Januszewicz M; Kała M; Witkowski A; Więcek A; Narkiewicz K; Somers VK; Januszewicz A
    J Hum Hypertens; 2013 Nov; 27(11):678-85. PubMed ID: 23698004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on diagnosis and treatment of resistant hypertension.
    Pimenta E
    Iran J Kidney Dis; 2011 Jul; 5(4):215-27. PubMed ID: 21725176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of aldosterone antagonists in resistant hypertension.
    Calhoun DA
    Prog Cardiovasc Dis; 2006; 48(6):387-96. PubMed ID: 16714158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistant hypertension and hyperaldosteronism.
    Gonzaga CC; Calhoun DA
    Curr Hypertens Rep; 2008 Dec; 10(6):496-503. PubMed ID: 18959838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep apnea, aldosterone, and resistant hypertension.
    Pimenta E; Calhoun DA; Oparil S
    Prog Cardiovasc Dis; 2009; 51(5):371-80. PubMed ID: 19249443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Aldosteronism and Obstructive Sleep Apnea: Is This A Bidirectional Relationship?
    Prejbisz A; Kołodziejczyk-Kruk S; Lenders JWM; Januszewicz A
    Horm Metab Res; 2017 Dec; 49(12):969-976. PubMed ID: 29202496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report.
    Gaddam K; Pimenta E; Thomas SJ; Cofield SS; Oparil S; Harding SM; Calhoun DA
    J Hum Hypertens; 2010 Aug; 24(8):532-7. PubMed ID: 20016520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperaldosteronism as a common cause of resistant hypertension.
    Calhoun DA
    Annu Rev Med; 2013; 64():233-47. PubMed ID: 23092384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistant hypertension: who and how to evaluate.
    Acelajado MC; Calhoun DA
    Curr Opin Cardiol; 2009 Jul; 24(4):340-4. PubMed ID: 19395953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone excess and resistance to 24-h blood pressure control.
    Pimenta E; Gaddam KK; Pratt-Ubunama MN; Nishizaka MK; Cofield SS; Oparil S; Calhoun DA
    J Hypertens; 2007 Oct; 25(10):2131-7. PubMed ID: 17885558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosteronism and resistant hypertension.
    Acelajado MC; Calhoun DA
    Int J Hypertens; 2011 Jan; 2011():837817. PubMed ID: 21331160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status.
    Ghazi L; Dudenbostel T; Lin CP; Oparil S; Calhoun DA
    J Hypertens; 2016 May; 34(5):1005-10. PubMed ID: 26886564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistant hypertension, obstructive sleep apnoea and aldosterone.
    Dudenbostel T; Calhoun DA
    J Hum Hypertens; 2012 May; 26(5):281-7. PubMed ID: 21654850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosteronism and hypertension.
    Calhoun DA
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1039-45. PubMed ID: 17699324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.